B. Huttner, S. Harbarth, D. Nathwani

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-C. Lagier Clinical Microbiology and Infection

Benchmarking inappropriate empirical antibiotic treatment

Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre J.M. Cisneros, O. Neth, M.V.

European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection S.B.

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis J.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics Y.H. van Beurden, S. Nezami,

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis G. Choudhury,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors S.B. Debast, N. Vaessen, A. Choudry,

Is antimicrobial stewardship cost-effective

R. Cantón Clinical Microbiology and Infection

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre.

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

E. Bouza Clinical Microbiology and Infection

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Single-dose antibiotic prophylaxis for urinary catheter removal does not reduce the risk of urinary tract infection in surgical patients: a randomized.

Vector control: a cornerstone in the malaria elimination campaign

Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland C. Pulcini, F. Williams, N. Molinari,

Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions

B. Gordts Clinical Microbiology and Infection

A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

Antibiotic usage and the incidence of resistance

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Levofloxacin in the treatment of ventilator-associated pneumonia

Mathematical modeling of Clostridium difficile infection

Metagenomics and probiotics

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

Laboratory diagnosis of Clostridium difficile disease

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

Benchmarking inappropriate empirical antibiotic treatment

The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.

Reducing antibiotic use in influenza: challenges and rewards

V. Vlahović-Palčevski, U. Dumpis, P. Mitt, J. Gulbinovič, J. Struwe, G

Clinical infection services—the Leiden experience

Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France B. Amadeo, C. Dumartin,

An after-hours clinical liaison blood culture service—is it worth it?

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre J.M. Cisneros, O. Neth, M.V.

W. Eugene Sanders, Christine C. Sanders

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

C.P. Kelly Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study

Abstracts Clinical Microbiology and Infection

Serum ferritin levels in West Nile encephalitis

New oral cephalosporins in pediatric community-acquired infections

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

Test results: characterising the antimicrobial activity of daptomycin

G.C. Schito Clinical Microbiology and Infection

Typing of Clostridium difficile

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

The future of diagnostic bacteriology

Presentation transcript:

Success stories of implementation of antimicrobial stewardship: a narrative review B. Huttner, S. Harbarth, D. Nathwani Clinical Microbiology and Infection Volume 20, Issue 10, Pages 954-962 (October 2014) DOI: 10.1111/1469-0691.12803 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Global success stories of antimicrobial stewardship (AMS) mentioned in this review. CDI, Clostridium difficile infection; DDD, defined daily doses; DID, defined daily doses/1000 inhabitants per day; Strama, Swedish Strategic Programme Against Antibiotic Resistance. Clinical Microbiology and Infection 2014 20, 954-962DOI: (10.1111/1469-0691.12803) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Gentamicin-induced acute kidney injury following the change in surgical prophylaxis antibiotics as part of a national stewardship programme in Scotland. (a) Increase in the percentage of acute kidney injury (adjusted) stages 1, 2 and 3 for each month (excluding neck of femur fractures) following the policy change. (b) No increase in the percentage of acute kidney injury stage 1, 2 and 3 for each month in patients with a neck of femur fracture. From [30] with permission. Clinical Microbiology and Infection 2014 20, 954-962DOI: (10.1111/1469-0691.12803) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Impact on antibiotic consumption following implementation of an an antimicrobial stewardship programme across a group of 54 private hospitals in South Africa (D. van den Bergh, personal communication; with permission of author). DID, defined daily doses/1000 inhabitants per day. Clinical Microbiology and Infection 2014 20, 954-962DOI: (10.1111/1469-0691.12803) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions